Literature DB >> 14563352

Chemokines and cytokines: axis and allies in asthma and allergy.

Jane M Schuh1, Kate Blease, Steven L Kunkel, Cory M Hogaboam.   

Abstract

Allergic asthma can be precipitated by many factors. For the atopic person, fungus, pollen, dust mites, cockroach antigens, and diesel exhaust are all agents that may trigger an allergic attack. Cytokines and chemokines are integral mediators of fungal asthma. From the earliest time points, they recruit and activate the cells required for the clearance of fungus as well as being critical factors involved in the immunopathology of this disease. In the final analysis, it is clear that these mediators can act to the benefit or the detriment of the host.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14563352     DOI: 10.1016/s1359-6101(03)00057-1

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  9 in total

1.  Therapeutic targeting of CCR1 attenuates established chronic fungal asthma in mice.

Authors:  Kristin J Carpenter; Jillian L Ewing; Jane M Schuh; Traci L Ness; Steven L Kunkel; Monica Aparici; Montserrat Miralpeix; Cory M Hogaboam
Journal:  Br J Pharmacol       Date:  2005-08       Impact factor: 8.739

2.  Targeting ST2L potentiates CpG-mediated therapeutic effects in a chronic fungal asthma model.

Authors:  Hemanth Ramaprakash; Takehiko Shibata; Karen E Duffy; Ugur B Ismailoglu; Rachel M Bredernitz; Ana Paula Moreira; Ana L Coelho; Anuk M Das; Natalie Fursov; Geoffrey L Chupp; Cory M Hogaboam
Journal:  Am J Pathol       Date:  2011-05-14       Impact factor: 4.307

3.  The Positively Charged COOH-terminal Glycosaminoglycan-binding CXCL9(74-103) Peptide Inhibits CXCL8-induced Neutrophil Extravasation and Monosodium Urate Crystal-induced Gout in Mice.

Authors:  Vincent Vanheule; Rik Janssens; Daiane Boff; Nikola Kitic; Nele Berghmans; Isabelle Ronsse; Andreas J Kungl; Flavio Almeida Amaral; Mauro Martins Teixeira; Jo Van Damme; Paul Proost; Anneleen Mortier
Journal:  J Biol Chem       Date:  2015-07-16       Impact factor: 5.157

4.  Angiotensin-(1-7) attenuates airway remodelling and hyperresponsiveness in a model of chronic allergic lung inflammation.

Authors:  G S Magalhães; M G Rodrigues-Machado; D Motta-Santos; A R Silva; M V Caliari; L O Prata; S C Abreu; P R M Rocco; L S Barcelos; R A S Santos; M J Campagnole-Santos
Journal:  Br J Pharmacol       Date:  2015-03-18       Impact factor: 8.739

5.  Triggering receptor expressed on myeloid cells-1 (TREM-1) modulates immune responses to Aspergillus fumigatus during fungal asthma in mice.

Authors:  Karen F Buckland; Hemanth Ramaprakash; Lynne A Murray; Kristin J Carpenter; Esther S Choi; Steven L Kunkel; Nicholas W Lukacs; Zhou Xing; Naoko Aoki; Dominik Hartl; Cory M Hogaboam
Journal:  Immunol Invest       Date:  2011-05-19       Impact factor: 3.657

Review 6.  Mononuclear phagocyte-mediated antifungal immunity: the role of chemotactic receptors and ligands.

Authors:  Muthulekha Swamydas; Timothy J Break; Michail S Lionakis
Journal:  Cell Mol Life Sci       Date:  2015-02-26       Impact factor: 9.261

7.  Intranasal CpG therapy attenuated experimental fungal asthma in a TLR9-dependent and -independent manner.

Authors:  Hemanth Ramaprakash; Cory M Hogaboam
Journal:  Int Arch Allergy Immunol       Date:  2009-12-16       Impact factor: 2.749

8.  Toll-like receptor 9 modulates immune responses to Aspergillus fumigatus conidia in immunodeficient and allergic mice.

Authors:  Hemanth Ramaprakash; Toshihiro Ito; Theodore J Standiford; Steven L Kunkel; Cory M Hogaboam
Journal:  Infect Immun       Date:  2008-10-20       Impact factor: 3.441

9.  Biomarkers of disease and treatment in murine and cynomolgus models of chronic asthma.

Authors:  Jennifer Louten; Jeanine D Mattson; Maria-Christina Malinao; Ying Li; Claire Emson; Felix Vega; Robert L Wardle; Michael R Van Scott; Robert B Fick; Terrill K McClanahan; Rene de Waal Malefyt; Maribel Beaumont
Journal:  Biomark Insights       Date:  2012-07-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.